Abstract
AbstractTwo new lanthanide-complexes based on the 5-nitropicolinate ligand (5-npic) were obtained and fully characterized. Single-crystal X-ray diffraction revealed that these compounds are isostructural to a Dy-complex, previously published by us, based on dinuclear monomers link together with an extended hydrogen bond network, providing a final chemical formula of [Ln2(5-npic)6(H2O)4]·(H2O)2, where Ln = Dy (1), Gd (2), and Tb (3). Preliminary photoluminescent studies exhibited a ligand-centered emission for all complexes. The potential antitumoral activity of these materials was assayed in a prostatic cancer cell line (PC-3; the 2nd most common male cancerous disease), showing a significant anticancer activity (50–60% at 500 μg·mL−1). In turn, a high biocompatibility by both, the complexes and their precursors in human immunological HL-60 cells, was evidenced. In view of the strongest toxic effect in the tumoral cell line provided by the free 5-npic ligand (~ 40–50%), the overall anticancer complex performance seems to be triggered by the presence of this molecule.
Graphical Abstract
Funder
European Union
Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía
Ministerio de Ciencia e Innovación
Universidad de Granada
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. World Health Organization, Cancer, https://www.who.int/health-topics/cancer#tab=tab_1. Accessed 10 Sept 2023
2. Global Cancer Observatory, Cancer, https://gco.iarc.fr/, Accessed 10 Sept 2023
3. Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG (2021) The Lancet 398:1075–1090
4. EAU, Guidelines on Prostate Cancer, https://uroweb.org/guidelines/prostate-cancer/chapter/treatment, Accessed 15 Oct 2023
5. Evans AJ (2018) Mod Pathol 31:S110–S121
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献